Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Sublingual/Oral Immunotherapy for the Treatment of Peanut Allergy [Phase 1, Phase 2]

View source ↗

Summary

A randomized, double-blind, placebo-controlled pilot study assessed sublingual/oral immunotherapy for peanut allergy; the trial has completed and results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Drugs mentioned

• Sublingual/Oral Immunotherapy for Peanut Allergy (investigational)

Snippet

Sponsor: Johns Hopkins University | Conditions: Peanut Hypersensitivity, Food Hypersensitivity | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-07